Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.2M Sell
98,708
-563
-0.6% -$159K 0.14% 135
2026
Q1
$26.5M Buy
+99,271
New +$27.5M 0.17% 112
2025
Q4
Sell
-81,254
Closed -$23.4M 1169
2025
Q3
$23.4M Sell
81,254
-346
-0.4% -$102K 0.24% 70
2025
Q2
$27M Buy
81,600
+22,557
+38% +$7.27M 0.31% 58
2025
Q1
$19.4M Sell
59,043
-48
-0.1% -$14.5K 0.28% 57
2024
Q4
$16.3M Buy
59,091
+9,868
+20% +$3.15M 0.24% 70
2024
Q3
$17.1M Sell
49,223
-2,404
-5% -$828K 0.27% 62
2024
Q2
$17.1M Buy
51,627
+9,746
+23% +$3.36M 0.3% 46
2024
Q1
$15.2M Buy
41,881
+11,941
+40% +$3.93M 0.27% 62
2023
Q4
$8.97M Buy
29,940
+11,126
+59% +$3.25M 0.23% 89
2023
Q3
$5.38M Buy
18,814
+11,287
+150% +$3.22M 0.16% 157
2023
Q2
$2.11M Buy
7,527
+1,679
+29% +$437K 0.07% 374
2023
Q1
$1.49M Sell
5,848
-16,839
-74% -$4.91M 0.09% 235
2022
Q4
$7.52M Buy
22,687
+11,845
+109% +$3.75M 0.49% 44
2022
Q3
$3.01M Buy
10,842
+8,581
+380% +$2.41M 0.29% 94
2022
Q2
$596K Buy
+2,261
New +$583K 0.08% 219
2018
Q4
Sell
-17,244
Closed -$3.56M 94
2018
Q3
$3.56M Sell
17,244
-611
-3% -$113K 1.05% 9
2018
Q2
$3.03M Buy
+17,855
New +$3.09M 0.96% 22

Other funds holding CI

Empowered Funds's CI Position: Q2 2026 in Review

Empowered Funds reduced its Cigna (CI) stake by 0.57% in Q2 2026, selling an estimated $159K and leaving 98,708 shares worth $27.2M. The position accounts for 0.14% of the portfolio, ranked #135.

Empowered Funds first reported a position in CI in Q2 2018 and has held it in 18 quarters since. 1,692 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Empowered Funds held 98,708 shares of Cigna worth $27.2M as of Q2 2026.
  • Empowered Funds sold 563 Cigna shares in Q2 2026, an estimated $159K.
  • Cigna made up 0.14% of Empowered Funds's portfolio in Q2 2026, its #135 holding.
  • Empowered Funds first reported a position in Cigna in Q2 2018 and has held it in 18 quarters since.
  • 1,692 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.